Akechi T, Okuyama T, Onishi J, Morita T, Furukawa T A
Nagoya City University Medical School, Department of Psychiatry, Mizuho-cho, Mizuho-ku, Nagoya, Aichi, Japan, 467 8601.
Cochrane Database Syst Rev. 2008 Apr 16;2008(2):CD005537. doi: 10.1002/14651858.CD005537.pub2.
The most common psychiatric diagnosis among cancer patients is depression; this diagnosis is even more common among patients with advanced cancer. Psychotherapy is a patient-preferred and promising strategy for treating depression among cancer patients. Several systematic reviews have investigated the effectiveness of psychological treatment for depression among cancer patients. However, the findings are conflicting, and no review has focused on depression among patients with incurable cancer.
To investigate the effects of psychotherapy for treating depression among patients with advanced cancer by conducting a systematic review of randomized controlled trials (RCTs).
We searched the Cochrane Pain, Palliative and Supportive Care Group Register, The Cochrane Controlled Trials Register, MEDLINE, EMBASE, CINAHL, and PsycINFO databases in September 2005.
All relevant RCTs comparing any kind of psychotherapy with conventional treatment for adult patients with advanced cancer were eligible for inclusion. Two independent review authors identified relevant studies.
Two review authors independently extracted data from the original reports using standardized data extraction forms. Two independent review authors also assessed the methodological quality of the selected studies according to the recommendations of a previous systematic review of psychological therapies for cancer patients that utilized ten internal validity indicators. The primary outcome was the standardized mean difference (SMD) of change between the baseline and immediate post-treatment scores.
We identified a total of ten RCTs (total of 780 participants); data from six studies were used for meta-analyses (292 patients in the psychotherapy arm and 225 patients in the control arm). Among these six studies, four studies used supportive psychotherapy, one adopted cognitive behavioural therapy, and one adopted problem-solving therapy. When compared with treatment as usual, psychotherapy was associated with a significant decrease in depression score (SMD = -0.44, 95% confidence interval [CI] = -0.08 to -0.80). None of the studies focused on patients with clinically diagnosed depression.
AUTHORS' CONCLUSIONS: Evidence from RCTs of moderate quality suggest that psychotherapy is useful for treating depressive states in advanced cancer patients. However, no evidence supports the effectiveness of psychotherapy for patients with clinically diagnosed depression.
癌症患者中最常见的精神科诊断是抑郁症;这种诊断在晚期癌症患者中更为常见。心理治疗是癌症患者治疗抑郁症的一种患者偏好且有前景的策略。几项系统评价已经研究了心理治疗对癌症患者抑郁症的有效性。然而,研究结果相互矛盾,且没有综述聚焦于无法治愈癌症患者的抑郁症。
通过对随机对照试验(RCT)进行系统评价,研究心理治疗对晚期癌症患者抑郁症的治疗效果。
我们于2005年9月检索了Cochrane疼痛、姑息和支持治疗组注册库、Cochrane对照试验注册库、MEDLINE、EMBASE、CINAHL和PsycINFO数据库。
所有比较任何一种心理治疗与成人晚期癌症患者常规治疗的相关RCT均符合纳入标准。两位独立的综述作者确定相关研究。
两位综述作者使用标准化数据提取表从原始报告中独立提取数据。两位独立的综述作者还根据先前一项利用十个内部效度指标的癌症患者心理治疗系统评价的建议,评估所选研究的方法学质量。主要结局是基线和治疗后即刻得分变化的标准化均数差(SMD)。
我们共确定了十项RCT(共780名参与者);六项研究的数据用于荟萃分析(心理治疗组292例患者,对照组225例患者)。在这六项研究中,四项研究使用支持性心理治疗,一项采用认知行为疗法,一项采用解决问题疗法。与常规治疗相比,心理治疗与抑郁评分显著降低相关(SMD = -0.44,95%置信区间[CI] = -0.08至-0.80)。没有一项研究聚焦于临床诊断为抑郁症的患者。
中等质量RCT的证据表明,心理治疗对晚期癌症患者的抑郁状态有用。然而,没有证据支持心理治疗对临床诊断为抑郁症患者的有效性。